Zobrazeno 1 - 7
of 7
pro vyhledávání: '"L I Olbinskaya"'
Publikováno v:
Терапевтический архив, Vol 78, Iss 2, Pp 54-58 (2003)
Aim. To examine the course of chronic cardiac failure (CCF), morphofunctional parameters of the heart in correlation with activity of cytokine system; to evaluate effectiveness, tolerance and safety of combined CCF treatment including a cardioselecti
Externí odkaz:
https://doaj.org/article/06b51cbf4b2e4c6390425584efbe74b5
Autor:
L I Olbinskaya, Yu A Danilogorskaya
Publikováno v:
Терапевтический архив, Vol 78, Iss 12, Pp 47-49 (2003)
Aim. To compare clinical, cost-effect efficacies and safety of simvastatin Zokor and generic Vasilip in correction of dislipoproteinemia in patients with ischemic heart disease. Material and methods. The original statin Zokor and generic statin Vasil
Externí odkaz:
https://doaj.org/article/4b24f9bcef0043f9b7efe64934daba6c
Autor:
L. I. Olbinskaya, Yu. I. Naymann
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 6, Iss 1, Pp 61-67 (2007)
Aim. To optimize chronic heart failure (CHF) pharmacotherapy, basing on endothelin (ET) system activity, functional and cardio-hemodynamic parameters, and their dynamics in beta-adrenoblocker nebivolol therapy. Material and methods. The study include
Externí odkaz:
https://doaj.org/article/b3779c40bcb3437ea2235c963411e6a3
Autor:
L. I. Olbinskaya, T. E. Morozova, B. G. Kukes, V. S. Zadionchenko, L. I. Pavlova, D. M. Sychev, I. V. Pogochenkova, Z. O. Grineva
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 5, Pp 70-73 (2002)
Antianginal and anti2ischemic effectiveness and tolerability of oxicardin in patients with stable angina of I-III functional classes: results of a Russian multicenter Russia.
Externí odkaz:
https://doaj.org/article/55b860de17ba4ce48ae7468d2ba7d817
Autor:
L. I. Olbinskaya, T. B. Andrushicina
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 3, Pp 43-46 (2001)
Clinical efficacy and safety of and A-2 antagonist eprosartan in patients with mild and moderate hypertension. Results of a multicenter trial.
Externí odkaz:
https://doaj.org/article/aa1f5d375ea74d8fa3bf4c971a57c907
Autor:
B. A. Hapayev, L. I. Olbinskaya
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 3, Pp 34-37 (2001)
We have estimated the 10-year absolute (AR) and relative (RR) cardiovascular risk in 30 patients (12 men and 18 women, mean age 55,5±7,2 years with essential hypertension, mild to severe (WHO/ISH, 1999) with the usage of a computer program dealing w
Externí odkaz:
https://doaj.org/article/f8ed89d8e1a14fb9859c878465e32a7c
Publikováno v:
Journal of human hypertension. 7(6)
The antihypertensive activity and the influence of adrenal cortex hormones of benazepril versus captopril were studied in 30 essential hypertensives in a double-blind, randomised, placebo-controlled trial during eight weeks of treatment. Patients sta